Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size study, By Drug (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies and Others }, Service (Target Identification and Validation, Lead screening and Characterization, Cell based Assays), By Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028
Global Cancer Immunotherapy Drug Discovery Outsourcing Market is valued approximately USD 1.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2028.
The popularity of the market is expanding as more doctors and patients are becoming aware of cancer immunotherapy, pharmaceutical and biotechnology companies are investing more in the research and development of cancer treatments, and the incidence of cancer is rising globally. Pharmaceutical corporations are also becoming more interested in immunotherapies as they lower the risk of cancer and demonstrate a decrease in tumour recurrence following chemotherapy. For instance, globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018, according to estimates from the International Agency for Research on Cancer (IARC). The estimated increase in the worldwide burden of cancer to 27.5 million new cases by 2040. Consequentially, growing mergers and acquisition is creating a new opportunity to the market. However, quality issues involved with drug discovery CRO services and intellectual property right issues impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Cancer Immunotherapy Drug Discovery Outsourcing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to presence of various large number of biotechnology and life sciences companies and key CROs in the region. Furthermore, government support towards cancer immunotherapy drug discovery outsourcing. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028 owing to increasing number of CROs that offers cost-effective drug discovery services, rise in use of advance technology, and large number of market players comply with Good Laboratory Practices (GLP) and follows regulatory guidelines effectively.
Major market players included in this report are:
Explicyte Immuno-Oncology
Aquila Biomedical
Horizon Discovery Group plc
Crown Bioscience Inc.
Promega Corporation.
HD Co. Ltd.
BPS Biosciences Inc.
Gen script Biotech Corporation
Celentyx Ltd.
ImmuneXperts SA
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug
Monoclonal Antibodies
Immunomodulators
Cancer Vaccines and Oncolytic Therapies
Others
By service:
Target Identification and Validation
Lead screening and Characterization
Cell based Assays
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Head and Neck Cancer
Ovarian Cancer
Pancreatic Cancer
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Cancer Immunotherapy Drug Discovery Outsourcing Market Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The popularity of the market is expanding as more doctors and patients are becoming aware of cancer immunotherapy, pharmaceutical and biotechnology companies are investing more in the research and development of cancer treatments, and the incidence of cancer is rising globally. Pharmaceutical corporations are also becoming more interested in immunotherapies as they lower the risk of cancer and demonstrate a decrease in tumour recurrence following chemotherapy. For instance, globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018, according to estimates from the International Agency for Research on Cancer (IARC). The estimated increase in the worldwide burden of cancer to 27.5 million new cases by 2040. Consequentially, growing mergers and acquisition is creating a new opportunity to the market. However, quality issues involved with drug discovery CRO services and intellectual property right issues impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Cancer Immunotherapy Drug Discovery Outsourcing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to presence of various large number of biotechnology and life sciences companies and key CROs in the region. Furthermore, government support towards cancer immunotherapy drug discovery outsourcing. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028 owing to increasing number of CROs that offers cost-effective drug discovery services, rise in use of advance technology, and large number of market players comply with Good Laboratory Practices (GLP) and follows regulatory guidelines effectively.
Major market players included in this report are:
Explicyte Immuno-Oncology
Aquila Biomedical
Horizon Discovery Group plc
Crown Bioscience Inc.
Promega Corporation.
HD Co. Ltd.
BPS Biosciences Inc.
Gen script Biotech Corporation
Celentyx Ltd.
ImmuneXperts SA
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug
Monoclonal Antibodies
Immunomodulators
Cancer Vaccines and Oncolytic Therapies
Others
By service:
Target Identification and Validation
Lead screening and Characterization
Cell based Assays
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Head and Neck Cancer
Ovarian Cancer
Pancreatic Cancer
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Cancer Immunotherapy Drug Discovery Outsourcing Market Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Drug, 2020-2028 (USD Billion)
1.2.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Service, 2020-2028 (USD Billion)
1.2.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Cancer Type, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET DYNAMICS
3.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing in-house R&D costs
3.1.1.2. Increasing adoption of advanced technologies
3.1.2. Market Challenges
3.1.2.1. Quality issues involved with drug discovery cro services
3.1.2.2. Intellectual property right issues
3.1.3. Market Opportunities
3.1.3.1. Growing mergers and acquisition
3.1.3.2. High prevelance of cancer
CHAPTER 4. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET, BY DRUG
6.1. Market Snapshot
6.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Drug, Performance - Potential Analysis
6.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Drug 2018-2028 (USD Billion)
6.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Immunomodulators
6.4.3. Cancer Vaccines and Oncolytic Therapies
6.4.4. Others
CHAPTER 7. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET, BY SERVICE
7.1. Market Snapshot
7.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Service, Performance - Potential Analysis
7.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Service 2018-2028 (USD Billion)
7.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
7.4.1. Target Identification and Validation
7.4.2. Lead screening and Characterization
7.4.3. Cell based Assays
CHAPTER 8. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET, BY CANCER TYPE
8.1. Market Snapshot
8.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type, Performance - Potential Analysis
8.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Cancer Type 2018-2028 (USD Billion)
8.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
8.4.1. Lung Cancer
8.4.2. Breast Cancer
8.4.3. Colorectal Cancer
8.4.4. Melanoma
8.4.5. Prostate Cancer
8.4.6. Head and Neck Cancer
8.4.7. Ovarian Cancer
8.4.8. Pancreatic Cancer
CHAPTER 9. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET, REGIONAL ANALYSIS
9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market, Regional Market Snapshot
9.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market
9.2.1. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market
9.2.1.1. Drug estimates & forecasts, 2018-2028
9.2.1.2. Service estimates & forecasts, 2018-2028
9.2.1.3. Cancer Type estimates & forecasts, 2018-2028
9.2.2. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.3.1. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.3. France Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.4. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.5. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.6. Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.4.1. China Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.2. India Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.3. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.4. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.5. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.6. Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market
9.5. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.5.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market
9.5.2. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market
9.6. Rest of The World Cancer Immunotherapy Drug Discovery Outsourcing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Explicyte Immuno-Oncology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Aquila Biomedical
10.2.3. Horizon Discovery Group plc
10.2.4. Crown Bioscience Inc.
10.2.5. Promega Corporation.
10.2.6. HD Co. Ltd.
10.2.7. BPS Biosciences Inc.
10.2.8. Gen script Biotech Corporation
10.2.9. Celentyx Ltd.
10.2.10. ImmuneXperts SA
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Drug, 2020-2028 (USD Billion)
1.2.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Service, 2020-2028 (USD Billion)
1.2.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Cancer Type, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET DYNAMICS
3.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing in-house R&D costs
3.1.1.2. Increasing adoption of advanced technologies
3.1.2. Market Challenges
3.1.2.1. Quality issues involved with drug discovery cro services
3.1.2.2. Intellectual property right issues
3.1.3. Market Opportunities
3.1.3.1. Growing mergers and acquisition
3.1.3.2. High prevelance of cancer
CHAPTER 4. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET, BY DRUG
6.1. Market Snapshot
6.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Drug, Performance - Potential Analysis
6.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Drug 2018-2028 (USD Billion)
6.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Immunomodulators
6.4.3. Cancer Vaccines and Oncolytic Therapies
6.4.4. Others
CHAPTER 7. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET, BY SERVICE
7.1. Market Snapshot
7.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Service, Performance - Potential Analysis
7.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Service 2018-2028 (USD Billion)
7.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
7.4.1. Target Identification and Validation
7.4.2. Lead screening and Characterization
7.4.3. Cell based Assays
CHAPTER 8. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET, BY CANCER TYPE
8.1. Market Snapshot
8.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type, Performance - Potential Analysis
8.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Cancer Type 2018-2028 (USD Billion)
8.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
8.4.1. Lung Cancer
8.4.2. Breast Cancer
8.4.3. Colorectal Cancer
8.4.4. Melanoma
8.4.5. Prostate Cancer
8.4.6. Head and Neck Cancer
8.4.7. Ovarian Cancer
8.4.8. Pancreatic Cancer
CHAPTER 9. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET, REGIONAL ANALYSIS
9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market, Regional Market Snapshot
9.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market
9.2.1. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market
9.2.1.1. Drug estimates & forecasts, 2018-2028
9.2.1.2. Service estimates & forecasts, 2018-2028
9.2.1.3. Cancer Type estimates & forecasts, 2018-2028
9.2.2. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.3.1. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.3. France Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.4. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.5. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.6. Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.4.1. China Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.2. India Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.3. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.4. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.5. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.6. Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market
9.5. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.5.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market
9.5.2. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market
9.6. Rest of The World Cancer Immunotherapy Drug Discovery Outsourcing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Explicyte Immuno-Oncology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Aquila Biomedical
10.2.3. Horizon Discovery Group plc
10.2.4. Crown Bioscience Inc.
10.2.5. Promega Corporation.
10.2.6. HD Co. Ltd.
10.2.7. BPS Biosciences Inc.
10.2.8. Gen script Biotech Corporation
10.2.9. Celentyx Ltd.
10.2.10. ImmuneXperts SA
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, report scope
TABLE 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Drug 2018-2028 (USD Billion)
TABLE 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Service 2018-2028 (USD Billion)
TABLE 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Cancer Type 2018-2028 (USD Billion)
TABLE 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Cancer Immunotherapy Drug Discovery Outsourcing Market
TABLE 56. List of primary sources, used in the study of global Cancer Immunotherapy Drug Discovery Outsourcing Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
TABLE 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, report scope
TABLE 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Drug 2018-2028 (USD Billion)
TABLE 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Service 2018-2028 (USD Billion)
TABLE 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Cancer Type 2018-2028 (USD Billion)
TABLE 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Cancer Immunotherapy Drug Discovery Outsourcing Market
TABLE 56. List of primary sources, used in the study of global Cancer Immunotherapy Drug Discovery Outsourcing Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, research methodology
FIG 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, key trends 2021
FIG 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, growth prospects 2022-2028
FIG 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, porters 5 force model
FIG 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, pest analysis
FIG 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, value chain analysis
FIG 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, regional snapshot 2018 & 2028
FIG 15. North America Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 16. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 19. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, company Market share analysis (2021)
FIG 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, research methodology
FIG 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, key trends 2021
FIG 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, growth prospects 2022-2028
FIG 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, porters 5 force model
FIG 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, pest analysis
FIG 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, value chain analysis
FIG 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, regional snapshot 2018 & 2028
FIG 15. North America Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 16. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 19. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, company Market share analysis (2021)
